HVC
IPXL

Healthcare Value Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Healthcare Value Capital’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-50,000
Closed -$1.5M – 43
2014
Q2 		$1.5M Buy
+50,000
New +$1.35M 1.26% 18

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Healthcare Value Capital's IPXL Position: Q3 2014 in Review

Healthcare Value Capital sold out of Impax Laboratories, Inc. (IPXL) in Q3 2014, closing a stake of 50,000 shares — an estimated $1.5M sold.

Healthcare Value Capital first reported a position in IPXL in Q2 2014 and held it in 1 quarter. The position peaked at $1.5M in Q2 2014. 162 funds tracked by Wall St. Rank hold IPXL as of Q3 2014.

  • Healthcare Value Capital reported no remaining Impax Laboratories, Inc. position as of Q3 2014 after selling out during the quarter.
  • Healthcare Value Capital sold 50,000 Impax Laboratories, Inc. shares in Q3 2014, an estimated $1.5M.
  • Healthcare Value Capital first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 1 quarter.
  • Healthcare Value Capital's Impax Laboratories, Inc. position peaked at $1.5M in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2014.

Based on Healthcare Value Capital's 13F filing for Q3 2014, filed 13 Nov 2014.